Technology Spillovers from Foreign Direct Investment in the Indian Pharmaceutical Industry
We examine whether knowledge spillovers from MNCs' local R&D activities benefit domestic firms in the Indian pharmaceutical industry from 1980-1994. In a policy environment that restricted FDI and provided weak intellectual property protection, we find that the only significant R&D spillovers in the Indian pharmaceutical sector were between MNCs and each other. We explore the implications of our findings in light of India's economic and industrial policy goals and implementation.© 2001 JIBS. Journal of International Business Studies (2001) 32, 421–437
Volume (Year): 32 (2001)
Issue (Month): 3 (September)
|Contact details of provider:|| Web page: http://www.palgrave-journals.com/|
Web page: https://aib.msu.edu/
|Order Information:||Web: http://www.springer.com/business+%26+management/journal/41267/PS2|
When requesting a correction, please mention this item's handle: RePEc:pal:jintbs:v:32:y:2001:i:3:p:421-437. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Sonal Shukla)or (Rebekah McClure)
If references are entirely missing, you can add them using this form.